AABB is among the various groups supporting the CDC's bid to establish a national "biovigilance" network that will use Web-based reporting systems to gather data on disease transmission and other complications caused by blood transfusions and transplants. The network is aimed at creating standard definitions to help hospitals prepare reports of labeling errors, injuries, allergic reactions and other kinds of transfusion-related adverse events.

Related Summaries